- New ETFs
- Bond ETFs
- Currency ETFs
- Emerging Market ETFs
- Commodity ETFs
- Broad U.S. Equity ETFs
- Sector ETFs
- Specialty ETFs
Cell Therapeutics, Inc. (CTIC) to Announce Q3 Report Financial Results on November 5
Recent Articles by BenzingaStaff1
- ATP Oil & Gas Corporation (ATPG) Declares Cash Dividend on Preferred Stock
- Crane Co. (CR) to Acquire Merrimac Industries
- Brady Corporation (BRC) Acquires Custom-Label and Nameplate Manufacturer in Brazil
- Carrollton Bancorp (CRRB) Announces Appointment of Mark A. Semanie as Chief Financial Officer
- Energy Transfer (ETE) Announces Appointment of New Directors
Company News
- Nike (NKE) Upgraded
- Large Trade in Hartford
- LSI Corporation (LSI) Upgraded To Buy; Price Target Raised
- Burger King (BKC) Upgraded
- Credit Suisse Maintains Public Service Enterprise Group (PEG) Outperform Rating
Earnings
- Top 5 NASDAQ Stocks In The Services Sector With The Highest Cash (NWSA, AMZN, EBAY, COST, LCAPA)
- Top 5 NASDAQ Stocks In the Services Sector With The Highest 5-Y Earnings Estimates (CTCM, MPEL, RENT, KTOS, UAUA)
- Top 5 NASDAQ Stocks in the Services Sector With The Highest Dividend (NRGP, STRA, NRGY, STON, CPLP)
- Benzinga’s Top Downgrades (ASTI , WAB, ARIA, WNS, WNI)
- Benzinga’s Top Upgrades (NKE, BF-B, CAR, BKC, MDTH)
Posted on 11/02/09 at 5:34am by Ben Zinga
Cell Therapeutics, Inc.'s (Nasdaq: CTIC) management team will host a conference call to discuss the Company's 2009 third quarter financial results Thursday, November 5.
Bookmark/Search this post with:
Related Articles
Today's Trading Ideas
Featured Articles
Related News from the Stock Market
There are 0 comments
Please note that comments may take up to one hour before they get published on the site. Please check back later to see your comments.
Post new comment
Receive Benzinga's Best 2010 Stock Idea!
